<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Waeber B</dc:creator>
  <dc:creator>Mourad JJ</dc:creator>
  <dc:creator>O'Brien E</dc:creator>
  <dc:date>2010</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Ambulatory blood pressure (BP) monitoring is increasingly used in the evaluation of hypertensive patients. The ability to monitor BP throughout the day and night allows the detection of abnormal nocturnal BP patterns, the most common being a "nondipping" pattern, which is associated with increased cardiovascular risk; its correction appears to have a positive impact on cardiovascular outcome. Antihypertensive treatment should be individually adjusted to control BP during both daytime and nighttime. However, drug-induced lowering of nocturnal BP, if excessive, could amplify the morning BP surge in patients with daytime BP elevation, increasing the risk of developing a cardiovascular event. Ambulatory BP monitoring therefore represents a unique tool to establish the most appropriate antihypertensive drug regimen for the individual patient.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/246027</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s11906-010-0152-0</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/20862569</dc:relation>
  <dc:source>Current hypertension reports. - 2010</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Antihypertensive Agents</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Blood Pressure</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Blood Pressure Monitoring, Ambulatory</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Case Management</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Drug Chronotherapy</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Evidence-Based Medicine</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Hypertension</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Periodicity</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Risk Factors</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Secondary Prevention</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Sleep Apnea, Obstructive</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Sleep Wake Disorders</dc:subject>
  <dc:title xmlns:ns14="xml" ns14:lang="en">Nighttime blood pressure: a target for therapy?</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
